Company Filing History:
Years Active: 2024
Title: **Innovations of Marco Sisignano in Pain Treatment**
Introduction
Marco Sisignano is an innovative inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pain management, specifically in the development of treatments for neuropathic pain related to chemotherapy. His pioneering work aims to enhance the quality of life for patients undergoing cancer treatment.
Latest Patents
Marco Sisignano holds a patent titled "CYP2J2 antagonists in the treatment of pain." This invention focuses on novel treatments for neuropathic pain, particularly chemotherapy-induced peripheral neuropathic pain (CIPNP). The invention introduces antagonists of cytochrome P450 epoxygenases (CYP), specifically targeting CYP2J2 as a therapeutic option. His research has demonstrated that these antagonists can alleviate CIPNP in vivo, enabling higher dosages of chemotherapeutics to be administered during cancer treatment without the concurrent increase in pain experienced by patients.
Career Highlights
Marco Sisignano works with the Fraunhofer Gesellschaft zur Förderung der Angewandten Forschung e.V., a prestigious research institution known for its applied research in various fields. His focus on neuropathic pain treatment has distinguished him as a prominent figure in the medical and pharmaceutical sectors. His innovative approaches not only contribute to scientific advancements but also aim to improve treatment methodologies in real-world settings.
Collaborations
Marco collaborates with Christian Brenneis, another talented researcher who shares his commitment to advancing pain management techniques. Their partnership highlights the importance of teamwork in fostering innovation and achieving breakthroughs in research.
Conclusion
Marco Sisignano exemplifies the spirit of innovation through his dedication to addressing the challenges faced in pain management, particularly for cancer patients. His work on CYP2J2 antagonists not only brings hope for more effective treatments but also underscores the vital role that inventors and researchers play in transforming healthcare solutions for those in need.